特发性炎症性肌病的疾病特征与药物使用:一项通过分散式远程与传统门诊招募的多中心前瞻性观察研究
My PACER 多中心前瞻性观察研究纳入美国 120 例特发性炎症性肌病患者,其中远程招募队列(TRC)82 例、中心门诊队列(CBC)38 例。两队列人口学特征及多数临床因素相似,亚型分布无显著差异(P=0.85),但 TRC 患者使用生物制剂和传统合成改善病情抗风湿药(csDMARDs)更频繁(P<0.001 和 P=0.013)。
要点
- 远程招募与门诊招募的 IIM 患者在人口学和临床特征上相似。
- TRC 患者使用生物制剂(P<0.001)和 csDMARDs(P=0.013)更频繁。
- 远程研究方法可能有助于 IIM 临床研究的患者招募。
核心结论
- 远程研究招募产生的患者队列在人口学和临床上与门诊传统招募的患者相似,表明其用于临床研究中稳健且多样化患者招募的有效性。
研究设计与样本
- My PACER 是一项在美国开展的多中心前瞻性观察研究,通过传统面对面门诊就诊竞争性招募(中心队列 CBC)和通过移动应用或网站及社交媒体远程招募(远程研究队列 TRC)IIM 受试者,共纳入 120 例,其中 TRC 82 例、CBC 38 例。
主要发现
- 平均年龄 55±13.4 岁,女性占 75%,白种人占 81%,两队列人口学特征相似。
- 总体亚型分布为皮肌炎 41%、多发性肌炎 27%、抗合成酶综合征 23%、坏死性肌炎 9%,两队列亚型患病率相当(P=0.85)。
- 两组在肌酶、诊断延迟、就业状态、多种患者和医生报告结局、功能测试以及胸部 CT、肺功能测试和肌电图异常发现频率等多个临床因素上表现相似。
- TRC 患者使用生物制剂和 csDMARDs 更频繁(分别为 P<0.001 和 P=0.013)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Idiopathic inflammatory myopathies (IIM) are rare and characterized by heterogeneous manifestations and clinical trajectories. Utilizing tele-research methods has the potential to improve participant recruitment and advance the understanding of the disease. We aimed to evaluate disease characteristics in IIM patients throughout the USA and compare these parameters between patients recruited remotely through mobile application or website vs those recruited locally in myositis clinics. METHODS: 'Myositis Patient Centered Tele-Research' (My PACER) is a multicentre prospective observational study of US IIM subjects, competitively recruited through traditional in-person clinic visits [centre-based cohort (CBC)] and remotely using mobile application or website and social media [tele-research cohort (TRC)]. Data collection comprised baseline demographic and clinical variables, encompassing symptoms, organ involvement, diagnostic tests results and medication use. RESULTS: The study included 120 IIM patients, 82 in the TRC and 38 in the CBC. The average age was 55 ± 13.4, 75% females and 81% Caucasians. Both cohorts exhibited similar demographic characteristics. Overall, 41% dermatomyositis, 27% polymyositis, 23% anti-synthetase syndrome, and 9% necrotizing myositis patients were enrolled, with comparable subtypes prevalence among cohorts (P = 0.85). The groups demonstrated similarities in multiple clinical factors, including muscle enzymes, diagnostic delay, employment status, various patient and physician-reported outcomes, functional tests, and the frequency of abnormal findings in chest CT, pulmonary function tests and electromyography. TRC patients received biologics and csDMARDs more frequently (P < 0.001 and P = 0.013, respectively). CONCLUSION: Tele-research recruitment yielded a patient cohort resembling traditionally recruited patients demographically and clinically, indicating its effectiveness for robust and diverse patient recruitment in clinical studies.
引用
- Keret S, Silva RL, Chandra T, et al. Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolment. Rheumatology (Oxford). 2025. PMID: 39208289. doi:10.1093/rheumatology/keae467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。